Pharmacologic approaches to glycemic treatment: standards of medical care in Diabetes2020
She supports the translation of company priorities into actionable plans and operating rhythms, helping leaders execute effectively in a complex, highly regulated environment
As we approach this transition, we know you may have many questions about availability, substitutions, cost, insurance coverage, and more
As this article has outlined, the honest answers are troubling
Abstract: Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for obesity and type 2 diabetes, resulting in rapid or massive weight loss (MWL) that can profoundly affect facial adipose tissue (AT) and skin homeostasis
In 24% of those mismatches, the symptoms were more serious than the patient realized